WealthCare Investment Partners LLC Grows Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

WealthCare Investment Partners LLC lifted its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 0.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 10,348 shares of the financial services provider’s stock after buying an additional 96 shares during the period. WealthCare Investment Partners LLC’s holdings in iShares Biotechnology ETF were worth $1,375,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of IBB. Sequoia Financial Advisors LLC increased its holdings in shares of iShares Biotechnology ETF by 8.3% in the third quarter. Sequoia Financial Advisors LLC now owns 2,608 shares of the financial services provider’s stock worth $380,000 after buying an additional 199 shares during the period. Eastern Bank bought a new stake in shares of iShares Biotechnology ETF in the third quarter worth about $65,000. SOL Capital Management CO grew its stake in shares of iShares Biotechnology ETF by 0.5% in the third quarter. SOL Capital Management CO now owns 35,165 shares of the financial services provider’s stock worth $5,120,000 after purchasing an additional 190 shares during the last quarter. Lyell Wealth Management LP grew its stake in shares of iShares Biotechnology ETF by 3.4% in the third quarter. Lyell Wealth Management LP now owns 22,274 shares of the financial services provider’s stock worth $3,243,000 after purchasing an additional 735 shares during the last quarter. Finally, NorthCrest Asset Manangement LLC grew its stake in shares of iShares Biotechnology ETF by 12.3% in the third quarter. NorthCrest Asset Manangement LLC now owns 3,290 shares of the financial services provider’s stock worth $479,000 after purchasing an additional 360 shares during the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

NASDAQ IBB opened at $138.74 on Thursday. iShares Biotechnology ETF has a 1 year low of $123.60 and a 1 year high of $150.57. The business’s 50-day moving average is $135.53 and its 200 day moving average is $140.79.

iShares Biotechnology ETF Cuts Dividend

The firm also recently announced a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were paid a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.